Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- 7 February 2008
- journal article
- Published by Elsevier BV in Regulatory Peptides
- Vol. 146 (1-3), 243-249
- https://doi.org/10.1016/j.regpep.2007.10.001
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The pathophysiology of myocardial reperfusion: a pathologist's perspectiveHeart, 2006
- Preconditioning, postconditioning and their application to clinical cardiologyCardiovascular Research, 2006
- Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005Diabetologia, 2006
- Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological processInternational Journal of Cardiology, 2005
- Postconditioning Inhibits Mitochondrial Permeability TransitionCirculation, 2005
- GLP-1-(9–36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretionAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptorEuropean Journal of Pharmacology, 1996
- Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pigAmerican Journal of Physiology-Endocrinology and Metabolism, 1996
- Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like PeptideOnline Journal of Public Health Informatics, 1995
- Exon duplication and divergence in the human preproglucagon geneNature, 1983